Measurement of hypochromic red blood cells is not the first line procedure to identify the patient with iron deficiency

Nephrology Dialysis Transplantation

Volumn 13, Issue 4, 1998, Pages 850-851

  Hörl, Walter H ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; TRANSFERRIN;

ARTICLE; CONTROLLED STUDY; ERYTHROCYTE; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IRON DEFICIENCY ANEMIA; KIDNEY FAILURE; MEGALOBLASTIC ANEMIA; PRIORITY JOURNAL; RETICULOCYTE; CHEMISTRY;

ANEMIA, HYPOCHROMIC; HEMOGLOBINS; HUMANS; IRON; RETICULOCYTES;

EID: 0032044169     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.4.850     Document Type: Article

References (12)

1. Braun J, Lindner K, Schreiber M, Heidler RA, Hörl WH. Percentage of hypochromic red blood cells as predictor of erythropoetic and iron response after i.v. iron supplementation in maintenance haemodialysis patients. Nephrol Dial Transplant 1997; 12: 1173-1181
2. Baynes RD. Assessment of iron status. Clin Biochem 1996; 29: 209-215
3. Gokal R, Millard PR, Weatherall DJ, Callender STE, Ledingham JGG, Oliver DO. Iron metabolism in haemodialysis patients. A study of the management of iron therapy and overload. Q J Med 1979; 48: 369-391
4. Eschbach JW, Kelly MR, Haley NR, Abels RI, Adamson JW. Treatment of the anemia of progressive renal failure with recombinant human erythropoietin. N Engl J Med 1989; 321: 158-163
5. Sunder-Plassmann G, Hörl WH. Laboratory diagnosis of anaemia in dialysis patients: use of common laboratory tests. Curr Opin Nephrol Hypertens 1997; 6: 566-569
6. Macdougall IC, Cavill I, Hulme B, Bain B, McGregor E, McKay P, Sanders E, Coles GA, Williams JD. Detection of functional iron deficiency during erythropoietin treatment: a new approach. Br Med J 1992; 304: 225-226
7. Schaefer RM, Schaefer L. The hypochromic red cell: a new parameter for monitoring of iron supplementation during rhEPO therapy. J Perinat Med 1995; 23: 83-88
8. Drüeke TB, Bárány P, Cazzola M, et al. Management of iron deficiency in renal anemia: guidelines for the optimal therapeutic approach in erythropoietin-treated patients. Clin Nephrol 1997; 48: 1-8
9. Sunder-Plassmann G, Spitzauer S, Hörl WH. The dilemma of evaluating iron status in dialysis patients: limitations of available diagnostic procedures. Nephrol Dial Transplant 1997; 12: 1575-1580
10. Fishbane S, Galgano C, Langley RC, Canfield W, Maesaka JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217-222
11. Cavill I. The rejected reticulocyte. Br J Haematol 1993; 84: 563-565
12. Mestrez F, Corazza F, Cosyns B, Dratwa M. Reticulocyte hemoglobin concentration (CHCr): a sensivite tool to monitor iron needs in hemodialysis (HD) patients (pts). Nephrology 1997; 3 (Suppl 1): S190 (abstract)